Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000180

Chairperson & CEO sold 1,723 shares at an average $611.06 ($1,052,854)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-04 Sale : show line 1 in the form 10b5-1 −842 $610.29 $513,867 325,324 I
2026-11-04 Sale : show line 2 in the form 10b5-1 −403 $611.26 $246,337 324,921 I
2026-11-04 Sale : show line 3 in the form 10b5-1 −398 $612.06 $243,600 324,523 I
2026-11-04 Sale : show line 4 in the form 10b5-1 −80 $613.14 $49,051 324,443 I
Open-market sales · 1,723 sh · avg $611.06 · $1,052,854
Loading xslF345X06/primarydocument.xml…